Cardiac AI Monitoring and Diagnostics Market Analysis and Forecast Report to 2032

Market Research Report

A quick peek into the report

1.1   Global Market Outlook
1.1.1   Product Definition
1.1.2   Inclusion Criteria
1.1.3   Exclusion Criteria
1.1.4   Overview
1.1.4.1   Market Size and Growth Potential

2.1   Key Trends
2.1.1   Rising Number of Startups in the Market
2.1.2   Increased Awareness Regarding Preventative Measures and Personalized Treatment
2.1.3   Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
2.2   Opportunity Assessment
2.3   Regulatory Framework
2.3.1   Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
2.3.2   Regulatory Framework in the U.S.
2.3.3   Regulatory Framework in Europe
2.3.4   Regulatory Framework in Japan
2.3.5   Regulatory Framework in China
2.3.6   Regulatory Framework in the Other Countries
2.4   Patent Analysis
2.4.1   Awaited Technological Developments
2.4.1.1   Patent Analysis (by Country)
2.4.1.2   Patent Analysis (by Year)
2.5   Business Models
2.6   Case Studies
2.6.1   Case Study 1: Ultromics Limited
2.6.1.1   The EchoGo System
2.6.1.1.1   Developement
2.6.1.1.2   Use Case and Reliability
2.6.1.2   A Success Story
2.6.1.3   Partners and Recognitions
2.6.2   Case Study 2: CorVista Health, Inc.
2.6.2.1   The CorVista System
2.6.2.2   A Success Story
2.7   Ongoing Clinical Trials
2.8   Funding Scenario
2.9   End User Perception
2.10 Entry Barriers for New Entrants

3.1   Impact on the Overall Market
3.2   Pre-COVID-19 Scenario
3.3   During COVID-19 Scenario
3.4   Post COVID-19 Scenario

4.1   Impact Analysis
4.2   Business Drivers
4.2.1   High Burden of Cardiovascular Diseases Worldwide
4.2.2   Increasing Government Initiatives for AI Adoption
4.2.3   Growing Research in the Field of AI for Cardiology
4.2.4   Increasing Regulatory Approvals of Cardiac Diagnostics AI Medical Devices
4.2.5   Technological Advancements in the Field of Cardiac AI Diagnostics
4.3   Business Restraints
4.3.1   Hesitation in Adoption and Acceptance of AI-Enabled Solutions for Cardiac Diagnosis
4.4   Business Opportunities
4.4.1   Increasing Opportunities for AI-Enabled Cardiac Diagnosis Solutions in Emerging Economies
4.4.2   Partnerships and Alliances amongst Market Players Creating an Opportunity for Growth

5.1   Opportunity Assessment
5.2   Growth-Share Matrix
5.3   Software
5.4   Hardware

6.1   Opportunity Assessment
6.2   Growth-Share Matrix
6.3   Ischemic Heart Diseases/CAD
6.4   Cardiac Arrhythmias
6.5   Ischemic Stroke
6.6   Others

7.1   Opportunity Assessment
7.2   Growth-Share Matrix
7.3   Cardiac Diagnostics
7.3.1   Imaging
7.3.2   Electrocardiography-Based (ECG-Based)
7.3.3   Others
7.4   Cardiac Monitoring

8.1   Opportunity Assessment
8.2   Growth-Share Matrix
8.3   Hospitals
8.4   Diagnostic Centers
8.5   Other End Users

9.1   North America Cardiac AI Monitoring and Diagnostics Market
9.1.1   Key Findings and Opportunity Assessment
9.1.2   Digital Adoption
9.1.3   Market Dynamics
9.1.3.1   Impact Analysis
9.1.4   Market Sizing and Forecast
9.1.4.1   North America Cardiac AI Monitoring and Diagnostics Market (by Product)
9.1.4.2   North America Cardiac AI Monitoring and Diagnostics Market (by Type)
9.1.4.2.1   North America Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.1.4.3   North America Cardiac AI Monitoring and Diagnostics Market (by Application)
9.1.4.4   North America Cardiac AI Monitoring and Diagnostics Market (by End User)
9.1.4.5   North America Cardiac AI Monitoring and Diagnostics Market (by Country)
9.1.4.5.1   U.S.
9.1.4.5.1.1   Market Dynamics
9.1.4.5.1.2   Market Size and Forecast
9.1.4.5.1.2.1   U.S. Cardiac AI Monitoring and Diagnostics Market (by Product)
9.1.4.5.1.2.2   U.S. Cardiac AI Monitoring and Diagnostics Market (by Type)
9.1.4.5.1.2.2.1   U.S. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.1.4.5.1.2.3   U.S. Cardiac AI Monitoring and Diagnostics Market (by Application)
9.1.4.5.1.2.4   U.S. Cardiac AI Monitoring and Diagnostics Market (by End User)
9.1.4.5.2   Canada
9.1.4.5.2.1   Market Dynamics
9.1.4.5.2.2   Market Size and Forecast
9.1.4.5.2.2.1   Canada Cardiac AI Monitoring and Diagnostics Market (by Product)
9.1.4.5.2.2.2   Canada Cardiac AI Monitoring and Diagnostics Market (by Type)
9.1.4.5.2.2.2.1   Canada Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.1.4.5.2.2.3   Canada Cardiac AI Monitoring and Diagnostics Market (by Application)
9.1.4.5.2.2.4   Canada Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2   Europe Cardiac AI Monitoring and Diagnostics Market
9.2.1   Key Findings and Opportunity Assessment
9.2.2   Digital Adoption
9.2.3   Market Dynamics
9.2.3.1   Impact Analysis
9.2.4   Market Sizing and Forecast
9.2.4.1   Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.2   Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.2.1   Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.3   Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.4   Europe Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2.4.5   Europe Cardiac AI Monitoring and Diagnostics Market (by Country)
9.2.4.5.1   Germany
9.2.4.5.1.1   Market Dynamics
9.2.4.5.1.2   Market Size and Forecast
9.2.4.5.1.2.1   Germany Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.5.1.2.2   Germany Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.5.1.2.2.1   Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.5.1.2.3   Germany Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.5.1.2.4   Germany Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2.4.5.2   U.K.
9.2.4.5.2.1   Market Dynamics
9.2.4.5.2.2   Market Size and Forecast
9.2.4.5.2.2.1   U.K. Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.5.2.2.2   U.K. Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.5.2.2.2.1   U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.5.2.2.3   U.K. Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.5.2.2.4   U.K. Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2.4.5.3   France
9.2.4.5.3.1   Market Dynamics
9.2.4.5.3.2   Market Size and Forecast
9.2.4.5.3.2.1   France Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.5.3.2.2   France Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.5.3.2.2.1   France Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.5.3.2.3   France Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.5.3.2.4   France Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2.4.5.4   Italy
9.2.4.5.4.1   Market Dynamics
9.2.4.5.4.2   Market Size and Forecast
9.2.4.5.4.2.1   Italy Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.5.4.2.2   Italy Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.5.4.2.2.1   Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.5.4.2.3   Italy Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.5.4.2.4   Italy Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2.4.5.5   Spain
9.2.4.5.5.1   Market Dynamics
9.2.4.5.5.2   Market Size and Forecast
9.2.4.5.5.2.1   Spain Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.5.5.2.2   Spain Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.5.5.2.2.1   Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.5.5.2.3   Spain Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.5.5.2.4   Spain Cardiac AI Monitoring and Diagnostics Market (by End User)
9.2.4.5.6   Rest-of-Europe
9.2.4.5.6.1   Market Size and Forecast
9.2.4.5.6.1.1   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product)
9.2.4.5.6.1.2   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type)
9.2.4.5.6.1.2.1   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.2.4.5.6.1.3   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application)
9.2.4.5.6.1.4   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
9.3.1   Key Findings and Opportunity Assessment
9.3.2   Digital Adoption
9.3.3   Market Dynamics
9.3.3.1   Impact Analysis
9.3.4   Market Sizing and Forecast
9.3.4.1   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.2   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.2.1   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.3   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.4   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3.4.5   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country)
9.3.4.5.1   Japan
9.3.4.5.1.1   Market Dynamics
9.3.4.5.1.2   Market Size and Forecast
9.3.4.5.1.2.1   Japan Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.5.1.2.2   Japan Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.5.1.2.2.1   Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.5.1.2.3   Japan Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.5.1.2.4   Japan Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3.4.5.2   China
9.3.4.5.2.1   Market Dynamics
9.3.4.5.2.2   Market Size and Forecast
9.3.4.5.2.2.1   China Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.5.2.2.2   China Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.5.2.2.2.1   China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.5.2.2.3   China Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.5.2.2.4   China Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3.4.5.3   India
9.3.4.5.3.1   Market Dynamics
9.3.4.5.3.2   Market Size and Forecast
9.3.4.5.3.2.1   India Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.5.3.2.2   India Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.5.3.2.2.1   India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.5.3.2.3   India Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.5.3.2.4   India Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3.4.5.4   Australia
9.3.4.5.4.1   Market Dynamics
9.3.4.5.4.2   Market Size and Forecast
9.3.4.5.4.2.1   Australia Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.5.4.2.2   Australia Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.5.4.2.2.1   Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.5.4.2.3   Australia Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.5.4.2.4   Australia Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3.4.5.5   South Korea
9.3.4.5.5.1   Market Dynamics
9.3.4.5.5.2   Market Size and Forecast
9.3.4.5.5.2.1   South Korea Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.5.5.2.2   South Korea Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.5.5.2.2.1   South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.5.5.2.3   South Korea Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.5.5.2.4   South Korea Cardiac AI Monitoring and Diagnostics Market (by End User)
9.3.4.5.6   Rest-of-Asia-Pacific
9.3.4.5.6.1   Market Size and Forecast
9.3.4.5.6.1.1   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
9.3.4.5.6.1.2   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
9.3.4.5.6.1.2.1   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.3.4.5.6.1.3   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
9.3.4.5.6.1.4   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
9.4   Latin America Cardiac AI Monitoring and Diagnostics Market
9.4.1   Key Findings and Opportunity Assessment
9.4.2   Digital Adoption
9.4.3   Market Dynamics
9.4.3.1   Impact Analysis
9.4.4   Market Sizing and Forecast
9.4.4.1   Latin America Cardiac AI Monitoring and Diagnostics Market (by Product)
9.4.4.1.1   Latin America Cardiac AI Monitoring and Diagnostics Market (by Type)
9.4.4.1.1.1   Latin America Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.4.4.1.2   Latin America Cardiac AI Monitoring and Diagnostics Market (by Application)
9.4.4.1.3   Latin America Cardiac AI Monitoring and Diagnostics Market (by End User)
9.4.4.1.4   Latin America Cardiac AI Monitoring and Diagnostics Market (by Country)
9.4.4.1.5   Brazil
9.4.4.1.5.1   Market Dynamics
9.4.4.1.5.2   Market Size and Forecast
9.4.4.1.5.2.1   Brazil Cardiac AI Monitoring and Diagnostics Market (by Product)
9.4.4.1.5.2.2   Brazil Cardiac AI Monitoring and Diagnostics Market (by Type)
9.4.4.1.5.2.2.1   Brazil Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.4.4.1.5.2.3   Brazil Cardiac AI Monitoring and Diagnostics Market (by Application)
9.4.4.1.5.2.4   Brazil Cardiac AI Monitoring and Diagnostics Market (by End User)
9.4.4.1.6   Mexico
9.4.4.1.6.1   Market Dynamics
9.4.4.1.6.2   Market Size and Forecast
9.4.4.1.6.2.1   Mexico Cardiac AI Monitoring and Diagnostics Market (by Product)
9.4.4.1.6.2.2   Mexico Cardiac AI Monitoring and Diagnostics Market (by Type)
9.4.4.1.6.2.2.1   Mexico Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.4.4.1.6.2.3   Mexico Cardiac AI Monitoring and Diagnostics Market (by Application)
9.4.4.1.6.2.4   Mexico Cardiac AI Monitoring and Diagnostics Market (by End User)
9.4.4.1.7   Rest-of-Latin America
9.4.4.1.7.1   Market Size and Forecast
9.4.4.1.7.1.1   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Product)
9.4.4.1.7.1.2   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Type)
9.4.4.1.7.1.2.1   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.4.4.1.7.1.3   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Application)
9.4.4.1.7.1.4   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by End User)
9.5   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market
9.5.1   Key Findings and Opportunity Assessment
9.5.2   Digital Adoption
9.5.3   Market Dynamics
9.5.3.1   Impact Analysis
9.5.4   Market Sizing and Forecast
9.5.4.1   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Product)
9.5.4.2   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Type)
9.5.4.2.1   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.5.4.3   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Application)
9.5.4.4   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by End User)
9.5.4.5   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Country)
9.5.4.5.1   U.A.E.
9.5.4.5.1.1   Market Dynamics
9.5.4.5.1.2   Market Size and Forecast
9.5.4.5.1.2.1   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Product)
9.5.4.5.1.2.2   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Type)
9.5.4.5.1.2.2.1   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.5.4.5.1.2.3   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Application)
9.5.4.5.1.2.4   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by End User)
9.5.4.5.2   South Africa
9.5.4.5.2.1   Market Dynamics
9.5.4.5.2.2   Market Size and Forecast
9.5.4.5.2.2.1   South Africa Cardiac AI Monitoring and Diagnostics Market (by Product)
9.5.4.5.2.2.2   South Africa Cardiac AI Monitoring and Diagnostics Market (by Type)
9.5.4.5.2.2.2.1   South Africa Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.5.4.5.2.2.3   South Africa Cardiac AI Monitoring and Diagnostics Market (by Application)
9.5.4.5.2.2.4   South Africa Cardiac AI Monitoring and Diagnostics Market (by End User)
9.5.4.5.3   Israel
9.5.4.5.3.1   Market Dynamics
9.5.4.5.3.2   Market Size and Forecast
9.5.4.5.3.2.1   Israel Cardiac AI Monitoring and Diagnostics Market (by Product)
9.5.4.5.3.2.2   Israel Cardiac AI Monitoring and Diagnostics Market (by Type)
9.5.4.5.3.2.2.1   Israel Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.5.4.5.3.2.3   Israel Cardiac AI Monitoring and Diagnostics Market (by Application)
9.5.4.5.3.2.4   Israel Cardiac AI Monitoring and Diagnostics Market (by End User)
9.5.4.5.4   Rest-of-Middle East and Africa
9.5.4.5.4.1   Market Size and Forecast
9.5.4.5.4.1.1   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Product)
9.5.4.5.4.1.2   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Type)
9.5.4.5.4.1.2.1   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
9.5.4.5.4.1.3   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Application)
9.5.4.5.4.1.4   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by End User)

10.1   Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
10.2   Key Strategies and Developments
10.2.1   Regulatory and Legal Activities
10.2.2   Partnerships, Alliances, and Business Expansions
10.2.3   Funding Activities
10.2.4   New Offerings
10.2.5   Mergers and Acquisitions
10.3   Company Profiles
10.3.1   AliveCor Inc.
10.3.1.1   Company Overview
10.3.1.2   Role of AliveCor Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.1.3   Recent Developments
10.3.1.4   Analyst Perspective
10.3.2   Aidoc
10.3.2.1   Company Overview
10.3.2.2   Role of Aidoc in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.2.3   Key Developments
10.3.2.4   Analyst Perception
10.3.3   Boston Scientific Corporation
10.3.3.1   Company Overview
10.3.3.2   Role of Boston Scientific Corporation in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.3.3   Financials
10.3.3.4   Analyst Perception
10.3.4   Canon Inc.
10.3.4.1   Company Overview
10.3.4.2   Role of Canon Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.4.3   Financials
10.3.4.4   Analyst Perception
10.3.5   CathWorks
10.3.5.1   Company Overview
10.3.5.2   Role of CathWorks in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.5.3   Key Developments
10.3.5.4   Analyst Perception
10.3.6   Circle Cardiovascular Imaging Inc.
10.3.6.1   Company Overview
10.3.6.2   Role of Circle Cardiovascular Imaging Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.6.3   Analyst Perception
10.3.7   General Electric Company
10.3.7.1   Company Overview
10.3.7.2   Role of General Electric Company in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.7.3   Financials
10.3.7.4   Analyst Perception
10.3.8   HeartFlow, Inc.
10.3.8.1   Company Overview
10.3.8.2   Role of HeartFlow, Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.8.3   Key Developments
10.3.8.4   Analyst Perception
10.3.9   iRhythm Technologies, Inc.
10.3.9.1   Company Overview
10.3.9.2   Role of iRhythm Technologies, Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.9.3   Financials
10.3.9.4   Key Developments
10.3.9.5   Analyst Perception
10.3.10   Koninklijke Philips N.V.
10.3.10.1   Company Overview
10.3.10.2   Role of Koninklijke Philips N.V. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.10.3   Financials
10.3.10.4   Key Developments
10.3.10.5   Analyst Perception
10.3.11   Medicalgorithmics S.A.
10.3.11.1   Company Overview
10.3.11.2   Role of Medicalgorithmics S.A. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.11.3   Key Developments
10.3.11.4   Analyst Perception
10.3.12   Nanox.AI Ltd.
10.3.12.1   Company Overview
10.3.12.2   Role of Nanox.AI Ltd. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.12.3   Key Developments
10.3.12.4   Analyst Perception
10.3.13   Siemens Healthineers AG
10.3.13.1   Company Overview
10.3.13.2   Role of Siemens Healthineers AG in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.13.3   Financials
10.3.13.4   Analyst Perception
10.3.14   Tempus Labs, Inc.
10.3.14.1   Company Overview
10.3.14.2   Role of Tempus Labs, Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.14.3   Key Developments
10.3.14.4   Analyst Perception
10.3.15   Ultromics Limited.
10.3.15.1   Company Overview
10.3.15.2   Role of Ultromics Limited. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.15.3   Key Developments
10.3.15.4   Analyst Perception
10.3.16   Viz.ai, Inc.
10.3.16.1   Company Overview
10.3.16.2   Role of Viz.ai, Inc. in the Global Cardiac AI Monitoring and Diagnostics Market
10.3.16.3   Key Developments
10.3.16.4   Analyst Perception

Table 1:   Regulatory Framework
Table 2:   Key Questions Answered in the Report
Table 3:   Startups Entering the Market
Table 4:   Regulatory Framework of Different Countries
Table 5:   Global Cardiac AI Monitoring and Diagnostics Market, Awaited Technological Developments
Table 6:   CorVista Health Inc. Publications
Table 7:   Global Cardiac AI Monitoring and Diagnostics Market, Ongoing Clinical Trials
Table 8:   Investments and Fundings in Cardiac AI Monitoring and Diagnostics Market
Table 9:   Applications of Artificial Intelligence in Cardiology During COVID-19 Pandemic
Table 10:   North America Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 11:   Europe Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 12:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 13:   Total Deaths and CVD Death Rates of Men/Women in 2018 in Japan (Per 100,000 of the Population)
Table 14:   Latin America Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 15:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Table 16:   Cardiac AI Monitoring and Diagnostics Active Players Ecosystem

Figure 1:   AI in Cardiac Monitoring and Diagnosis
Figure 2:   Global Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 3:   Global Cardiac AI Monitoring and Diagnostics Market, Market Dynamics
Figure 4:   Key Trends in the Global Cardiac AI Monitoring and Diagnostics Market
Figure 5:   Entry Barriers for New Entrants
Figure 6:   Global Cardiac AI Monitoring and Diagnostics Market Share (by Product), 2022 and 2032
Figure 7:   Global Cardiac AI Monitoring and Diagnostics Market Share (by Type), 2022 and 2032
Figure 8:   Global Cardiac AI Monitoring and Diagnostics Market Share (by Application), 2022 and 2032
Figure 9:   Global Cardiac AI Monitoring and Diagnostics Market Share (by End Users), 2022 and 2032
Figure 10:   Global Cardiac AI Monitoring and Diagnostics Market (by Region), $Million, 2022
Figure 11:   Key Developments and Strategies Analysis, January 2020-June 2023
Figure 12:   Global Cardiac AI Monitoring and Diagnostics Market Segmentation
Figure 13:   Global Cardiac AI Monitoring and Diagnostics Market: Research Methodology
Figure 14:   Primary Research Methodology
Figure 15:   Bottom-Up Approach (Segment-Wise Analysis)
Figure 16:   Top-Down Approach (Segment-Wise Analysis)
Figure 17:   Overview of the Role of AI in Cardiology
Figure 18:   Global Cardiac AI Monitoring and Diagnostics Market, Size and Growth Potential, $Million, 2022-2032
Figure 19:   Global Cardiac AI Monitoring and Diagnostics Market, Key Trends
Figure 20:   Potential of AI for Processing Patient's Own Data
Figure 21:   Advantages of AI-Enabled Wearable Sensors for Cardiac Monitoring
Figure 22:   Global Cardiac AI Monitoring and Diagnostics Market, Key Trends, Opportunity Assessment, 2023-2032
Figure 23:   Regulatory Process for Medical Devices in the U.S.
Figure 24:   Global Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Country), January 2018-June 2023
Figure 25:   Global Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Year), January 2018-June 2023
Figure 26:   Different Types of Business Models in the AI in Healthcare Scenario
Figure 27:   Subscription-Based Model the Market is Shifting Towards
Figure 28:   Partners of Ultromics Limited
Figure 29:   Ultromics Limited:Awards and Recognitions
Figure 30:   The CorVista System
Figure 31:   Global Cardiac AI Monitoring and Diagnostics Market, Quarterly Analysis of Funding Scenario, January 2020-June 2023
Figure 32:   Cardiac AI Monitoring and Diagnostics Market, End User Perceptions
Figure 33:   Entry Barriers for New Entrants
Figure 34:   Recommendations to Tackle the Entry Barriers
Figure 35:   Tools and Technologies of AI for Cardiology During COVID-19
Figure 36:   Global Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
Figure 37:   Prevalence of Specific Cardiovascular Diseases (by Region), 2021
Figure 38:   Financial Burden of CVDs on Different Regions/Countries
Figure 39:   Government Initiatives for AI Adoption
Figure 40:   Number of Research Publications Related to AI/ML in Cardiac Diagnostics, 2010-2022
Figure 41:   Regulatory Approvals for Cardiac AI Diagnostics Products, January 2020-June 2023
Figure 42:   Technological Advancements in Cardiac AI Monitoring and Diagnostics
Figure 43:   Survey Results
Figure 44:   Gains from Partnerships and Alliances amongst Market Players
Figure 45:   Global Cardiac AI Monitoring and Diagnostics Market (by Product)
Figure 46:   Global Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Product), $Million, 2023-2032
Figure 47:   Global Cardiac AI Monitoring and Diagnostics Market, Growth-Share Matrix (by Product), 2022-2032
Figure 48:   Global Cardiac AI Monitoring and Diagnostics Market (Software), $Million, 2022-2032
Figure 49:   Global Cardiac AI Monitoring and Diagnostics Market (Hardware), $Million, 2022-2032
Figure 50:   Global Cardiac AI Monitoring and Diagnostics Market (by Application)
Figure 51:   Global Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Application), $Million, 2023-2032
Figure 52:   Global Cardiac AI Monitoring and Diagnostics Market, Growth-Share Matrix (by Application), 2022-2032
Figure 53:   Global Cardiac AI Monitoring and Diagnostics Market (Ischemic Heart Diseases/CAD), $Million, 2022-2032
Figure 54:   Global Cardiac AI Monitoring and Diagnostics Market (Cardiac Arrhythmias), $Million, 2022-2032
Figure 55:   Global Cardiac AI Monitoring and Diagnostics Market (Ischemic Stroke), $Million, 2022-2032
Figure 56:   Global Cardiac AI Monitoring and Diagnostics Market (Others), $Million, 2022-2032
Figure 57:   Global Cardiac AI Monitoring and Diagnostics Market (by Type)
Figure 58:   Global Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Type), $Million, 2023-2032
Figure 59:   Global Cardiac AI Monitoring and Diagnostics Market, Growth-Share Matrix (by Type), 2022-2032
Figure 60:   Global Cardiac AI Monitoring and Diagnostics Market (Cardiac Diagnostics), $Million, 2022-2032
Figure 61:   Use Cases of Artificial Intelligence in Cardiac Imaging
Figure 62:   Global Cardiac AI Monitoring and Diagnostics Market (Imaging), $Million, 2022-2032
Figure 63:   Global Cardiac AI Monitoring and Diagnostics Market (ECG-Based), $Million, 2022-2032
Figure 64:   Global Cardiac AI Monitoring and Diagnostics Market (Others), $Million, 2022-2032
Figure 65:   AI-Enabled Cardiac Monitoring Advantages
Figure 66:   Global Cardiac AI Monitoring and Diagnostics Market (Cardiac Monitoring), $Million, 2022-2032
Figure 67:   Global Cardiac AI Monitoring and Diagnostics Market (by End User)
Figure 68:   Global Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by End User), $Million, 2023-2032
Figure 69:   Global Cardiac AI Monitoring and Diagnostics Market, Growth-Share Matrix (by End Users), 2022-2032
Figure 70:   Global Cardiac AI Monitoring and Diagnostics Market (Hospitals), $Million, 2022-2032
Figure 71:   Global Cardiac AI Monitoring and Diagnostics Market (Diagnostic Centers), $Million, 2022-2032
Figure 72:   Global Cardiac AI Monitoring and Diagnostics Market (Other End Users), $Million, 2022-2032
Figure 73:   Global Cardiac AI Monitoring and Diagnostics Market Share (by Region), 2022-2032
Figure 74:   North America Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
Figure 75:   North America Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 76:   North America Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 77:   North America Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 78:   North America Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 79:   North America Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 80:   North America Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 81:   North America Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
Figure 82:   U.S. Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 83:   U.S. Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 84:   U.S. Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 85:   U.S. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 86:   U.S. Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 87:   U.S. Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 88:   Canada Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 89:   Canada Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 90:   Canada Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 91:   Canada Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 92:   Canada Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 93:   Canada Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 94:   Europe Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
Figure 95:   Digital Competence Framework for Citizens Developed by the European Commission
Figure 96:   Europe Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 97:   Europe Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 98:   Europe Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 99:   Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 100:   Europe Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 101:   Europe Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 102:   Europe Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
Figure 103:   Germany Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 104:   Germany Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 105:   Germany Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 106:   Germany Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 107:   Germany Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 108:   Germany Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 109:   U.K. Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 110:   U.K. Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 111:   U.K. Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 112:   U.K. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 113:   U.K. Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 114:   U.K. Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 115:   France Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 116:   France Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 117:   France Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 118:   France Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 119:   France Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 120:   France Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 121:   Italy Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 122:   Italy Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 123:   Italy Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 124:   Italy Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 125:   Italy Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 126:   Italy Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 127:   Spain Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 128:   Spain Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 129:   Spain Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 130:   Spain Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 131:   Spain Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 132:   Spain Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 133:   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 134:   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 135:   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 136:   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 137:   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 138:   Rest-of-Europe Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 139:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
Figure 140:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 141:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 142:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 143:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 144:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 145:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 146:   Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
Figure 147:   Japan Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 148:   Japan Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 149:   Japan Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 150:   Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 151:   Japan Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 152:   Japan Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 153:   China Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 154:   China Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 155:   China Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 156:   China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 157:   China Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 158:   China Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 159:   India Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 160:   India Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 161:   India Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 162:   India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 163:   India Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 164:   India Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 165:   Australia Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 166:   Australia Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 167:   Australia Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 168:   Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 169:   Australia Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 170:   Australia Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 171:   South Korea Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 172:   South Korea Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 173:   South Korea Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 174:   South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 175:   South Korea Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 176:   South Korea Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 177:   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 178:   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 179:   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 180:   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 181:   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 182:   Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 183:   Latin America Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2022-2032
Figure 184:   Latin America Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 185:   Latin America Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 186:   Latin America Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 187:   Latin America Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 188:   Latin America Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 189:   Latin America Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 190:   Latin America Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2023 and 2032
Figure 191:   Brazil Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 192:   Brazil Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 193:   Brazil Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 194:   Brazil Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 195:   Brazil Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 196:   Brazil Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 197:   Mexico Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 198:   Mexico Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 199:   Mexico Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 200:   Mexico Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 201:   Mexico Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 202:   Mexico Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 203:   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 204:   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 205:   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 206:   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 207:   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 208:   Rest-of-Latin America Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 209:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
Figure 210:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 211:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 212:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 213:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 214:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 215:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 216:   Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
Figure 217:   U.A.E. Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 218:   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 219:   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 220:   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 221:   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 222:   U.A.E. Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 223:   South Africa Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 224:   South Africa Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 225:   South Africa Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 226:   South Africa Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 227:   South Africa Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 228:   South Africa Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 229:   Israel Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 230:   Israel Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 231:   Israel Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 232:   Israel Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 233:   Israel Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 234:   Israel Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 235:   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
Figure 236:   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
Figure 237:   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
Figure 238:   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
Figure 239:   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
Figure 240:   Rest-of-Middle East and Africa Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
Figure 241:   Share of Key Developments and Strategies, January 2019-June 2023
Figure 242:   Regulatory and Legal Activities (by Company), January 2019-June 2023
Figure 243:   Partnerships, Alliances, and Business Expansions (by Company), January 2019-June 2023
Figure 244:   Funding Activities (by Company), January 2019-June 2023
Figure 245:   New Offerings (by Company), January 2019-June 2023
Figure 246:   Mergers and Acquisitions (by Company), January 2019-June 2023
Figure 247:   AliveCor Inc.: Overall Product Portfolio
Figure 248:   Aidoc.: Overall Product Portfolio
Figure 249:   Boston Scientific Corporation: Overall Product Portfolio
Figure 250:   Boston Scientific Corporation: Overall Financials, $Million, 2020-2022
Figure 251:   Boston Scientific Corporation: Net Revenue (by Segment), $Million, 2020-2022
Figure 252:   Boston Scientific Corporation: Net Revenue (by Region), $Million, 2020-2022
Figure 253:   Boston Scientific Corporation: R&D Expenditure, $Million, 2020-2022
Figure 254:   Canon Inc.: Overall Product Portfolio
Figure 255:   Canon Inc.: Overall Financials, $Million, 2020-2022
Figure 256:   Canon Inc.: Net Revenue (by Segment), $Million, 2020-2021
Figure 257:   Canon Inc.: Net Revenue (by Segment), $Million, 2022
Figure 258:   Canon Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 259:   Canon Inc.: R&D Expenditure, $Million, 2020-2022
Figure 260:   CathWorks: Overall Product Portfolio
Figure 261:   Circle Cardiovascular Imaging Inc.: Overall Product Portfolio
Figure 262:   General Electric Company: Overall Product Portfolio
Figure 263:   General Electric Company: Overall Financials, $Million, 2020-2022
Figure 264:   General Electric Company: Net Revenue (by Segment), $Million, 2020-2022
Figure 265:   General Electric Company: Net Revenue (by Region), $Million, 2020-2022
Figure 266:   General Electric Company: R&D Expenditure, $Million, 2020-2022
Figure 267:   HeartFlow, Inc.: Overall Product Portfolio
Figure 268:   iRhythm Technologies, Inc.: Overall Product Portfolio
Figure 269:   iRhythm Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 270:   iRhythm Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 271:   Koninklijke Philips N.V.: Overall Product Portfolio
Figure 272:   Koninklijke Philips N.V.: Overall Financials, $Million, 2020-2022
Figure 273:   Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2020-2022
Figure 274:   Koninklijke Philips N.V.: Revenue (by Region), $Million, 2020-2022
Figure 275:   Koninklijke Philips N.V.: R&D Expenditure, $Million, 2022-2022
Figure 276:   Medicalgorithmics S.A.: Overall Product Portfolio
Figure 277:   Nanox.AI Ltd.: Overall Product Portfolio
Figure 278:   Siemens Healthineers AG: Overall Product Portfolio
Figure 279:   Siemens Healthineers AG: Overall Financials, $Million, 2020-2022
Figure 280:   Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2020-2022
Figure 281:   Siemens Healthineers AG: Net Revenue (by Region), $Million, 2020-2022
Figure 282:   Siemens Healthineers AG: R&D Expenditure, $Million, 2020-2022
Figure 283:   Tempus Labs, Inc.: Overall Product Portfolio
Figure 284:   Ultromics Limited.: Overall Product Portfolio
Figure 285:   Viz.ai, Inc.: Overall Product Portfolio

Market Report Coverage

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled:

•   AliveCor Inc.
•   Aidoc
•   Boston Scientific Corporation
•   Canon Inc.
•   CathWorks
•   Circle Cardiovascular Imaging Inc.
•   General Electric Company
•   HeartFlow, Inc.
•   iRhythm Technologies, Inc.
•   Koninklijke Philips N.V.
•   Medicalgorithmics S.A.
•   Nanox.AI Ltd.
•   Siemens Healthineers AG
•   Tempus Labs, Inc.
•   Ultromics Limited.
•   Viz.ai, Inc.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The global cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Regulatory activities accounted for the maximum number of key developments, i.e., nearly 33.33% of the total developments in the global cardiac AI monitoring and diagnostics market, as of June 2023.

Industry and Technology Overview

Intro on Cardiac AI Monitoring and Diagnostics Market

The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022 and is anticipated to reach $10,666.5 million by 2032, witnessing a CAGR of 26.88% during the forecast period 2023-2032. The key factors driving the growth of the global cardiac AI monitoring and diagnostics market include the high burden of cardiovascular diseases worldwide, increasing government initiatives for AI adoption, growing research in the field of AI for cardiology, increasing regulatory approvals of cardiac diagnostics AI medical devices and technological advancements in the field of cardiac AI diagnostics.

Market Introduction

Cardiac AI monitoring and diagnostics refers to the application of artificial intelligence (AI) technologies in the field of cardiology to monitor, analyze, and diagnose various cardiac conditions. AI algorithms are trained on large datasets of cardiac images, patient data, and clinical outcomes to develop models that can assist healthcare professionals in interpreting cardiac diagnostic tests and making treatment decisions. This emerging area of medical technology aims to improve the accuracy, efficiency, and accessibility of cardiac care.

Impact

Cardiac AI monitoring and diagnostics market has made an impact in the following ways:

Improved Accuracy and Efficiency: AI-powered algorithms can analyze vast amounts of cardiac data with exceptional accuracy and speed. This enables quicker and more precise diagnoses, leading to timely interventions and better patient outcomes.

Early Detection of Heart Conditions: AI-based monitoring systems can detect subtle changes in cardiac patterns, allowing for the early identification of potential heart conditions, such as arrhythmias or abnormal rhythms. Early detection of such conditions also enables early intervention, reducing the risk of complications and costly treatments.

Remote Patient Monitoring: AI-powered cardiac monitoring solutions enable remote patient monitoring, allowing healthcare providers to continuously track patients' heart health outside traditional healthcare settings. This leads to better disease management, reduced hospitalizations, and improved patient convenience.

Personalized Treatment Plans: AI algorithms can analyze individual patient data, including medical history, genetics, and lifestyle factors, to tailor treatment plans specifically for each patient. This personalized approach leads to more effective treatments and reduces the likelihood of adverse reactions to medications.

Bridging Healthcare Gaps: AI-based cardiac monitoring and diagnostics can be utilized in underserved areas and remote regions where access to specialized cardiac care is limited. By leveraging AI technology, healthcare services become more accessible and affordable to a broader population.

Research and Development: The data gathered through AI monitoring and diagnostics can contribute to medical research and the development of new treatments and medications. AI's ability to process and analyze vast datasets accelerates the pace of medical advancements in the field of cardiology.

Cost Savings: Timely and accurate diagnoses, along with remote monitoring capabilities, can lead to cost savings for both healthcare providers and patients. By preventing unnecessary hospitalizations and complications, AI-powered solutions reduce the overall healthcare expenditure.

Impact of COVID-19

During the COVID-19 pandemic, AI technology was employed to predict congestive heart failure in COVID-19 patients by analyzing vital signs related to heart disease. It also aided in the assessment of disease history and prescribing appropriate medications for treatment. Moreover, the COVID-19 pandemic highlighted the advantages of the implementation of AI in cardiology. Thereby, the COVID-19 pandemic had a positive impact on the overall cardiac AI monitoring and diagnostics market since it led to increased emphasis on remote monitoring, increased demand for early detection and proactive care, and acceleration of technological advancements in the field of cardiac diagnosis and monitoring.

Market Segmentation:

Segmentation 1: by Product
• Software
• Hardware

Software to Dominate the Global Cardiac AI Monitoring and Diagnostics Market (by Product)

Software: Software plays a critical role in the development of AI-based medical devices. AI-based medical devices rely on sophisticated software tools that are designed to analyze medical data, images, and other inputs to provide accurate monitoring, diagnosis, and provide treatment recommendations. These software tools typically include machine learning and deep learning algorithms that are trained on large datasets of medical images and clinical data to identify patterns and predictions.

Hardware: Hardware for cardiac monitoring and diagnosis includes the combination of artificial intelligence (AI) algorithms and specialized hardware devices designed to enhance the accuracy, efficiency, and accessibility of cardiac healthcare. These hardware devices are specifically developed to integrate AI capabilities into the monitoring and diagnostic processes, enabling advanced data analysis, real-time insights, and improved patient care.

Segmentation 2: by Type
•   Cardiac Diagnostics
o   Imaging
o   ECG-Based
o   Others
•   Cardiac Monitoring

Cardiac Diagnostics Occupy the Largest Share in the Global Cardiac AI Monitoring and Diagnostics (by Type)

Cardiac Diagnostics: Cardiac diagnostics refers to the process of identifying and determining the presence, nature, and extent of cardiac diseases or abnormalities in an individual. The goal of cardiac diagnosis is to accurately identify the underlying cardiac condition, which helps guide appropriate treatment and management strategies. The integration of artificial intelligence (AI) into cardiac diagnosis involves leveraging AI algorithms and techniques to augment and enhance the diagnostic process. It has the potential to enhance accuracy, efficiency, and accessibility while supporting healthcare professionals in providing optimal care to patients. AI can help in cardiac diagnosis by performing data analysis of large volumes of cardiac data, including medical records, images, test results, and patient characteristics, analyzing medical images, such as echocardiograms, angiograms, or cardiac MRI scans, analyzing electrocardiogram (ECG) signals to detect and classify various arrhythmias and other cardiac abnormalities, or by providing AI-based decision support.

Cardiac Monitoring: Cardiac monitoring refers to the continuous or periodic monitoring of a patient's heart activity, typically through the use of specialized devices or systems. It involves the recording, analysis, and interpretation of various cardiac parameters to assess heart function, detect abnormalities, and monitor cardiac conditions. The integration of AI into monitoring devices or systems enhances the accuracy, efficiency, and insights derived from the collected data. By leveraging AI algorithms, healthcare professionals can gain a deeper understanding, make timely interventions, and provide more targeted care to individuals with cardiac conditions, ultimately improving patient outcomes and quality of life.

Segmentation 3: by Application
•   Ischemic Heart Disease/CAD
•   Cardiac Arrhythmias
•   Ischemic Stroke
•   Others

Ischemic Heart Diseases/CAD Segment to Hold the Highest Share of the Market due to the High Prevalence

Ischemic Heart Diseases/CAD: Ischemic heart disease, also known as coronary artery disease (CAD), is a condition that occurs when the blood vessels supplying blood to the heart (coronary arteries) become narrowed or blocked, leading to reduced blood flow and oxygen to the heart muscle. CAD is the most common type of heart disease and a leading cause of heart attacks. The primary cause of CAD is atherosclerosis, a condition characterized by the buildup of plaque on the inner walls of the coronary arteries. Plaque consists of cholesterol, fat, calcium, and other substances. Over time, the plaque can harden and narrow the arteries, restricting blood flow. The increased prevalence of ischemic heart disease is fueling the demand for advanced solutions for monitoring and diagnosis, which is expected to propel the growth of the segment.

Cardiac Arrhythmias: Cardiac arrhythmia refers to abnormal heart rhythms or irregular heartbeats. The normal rhythm of the heart is maintained by electrical signals that coordinate the contractions of the heart's chambers. When these electrical signals are disrupted, it can lead to various types of arrhythmias. Some common types of arrhythmias include atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), supraventricular tachycardia (SVT), bradycardia, and premature ventricular contractions (PVCs).

Ischemic Stroke: An ischemic stroke is the most common type of stroke, accounting for about 80% of all strokes. It occurs when a blood clot or plaque buildup blocks or narrows a blood vessel, reducing or completely cutting off blood flow to a part of the brain. Without an adequate blood supply, the affected brain tissue is deprived of oxygen and nutrients, leading to damage and cell death.

Others: The others segment consists of other cardiac conditions such as hypertensive heart diseases, cardiomyopathy, valvular heart diseases, congenital heart diseases, and peripheral artery diseases, among others. AI has great potential to significantly impact the diagnosis and monitoring of these cardiac diseases, and several market players are working toward the implementation of AI for the diagnosis and monitoring of different cardiac diseases.

Segmentation 4: by End User
•   Hospitals
•   Diagnostic Centers
•   Other End Users

Hospitals to Dominate the Global Cardiac AI Monitoring and Diagnostics Market (by End User)

Based on end users, the hospital segment is expected to dominate the cardiac AI monitoring and diagnostics market. Hospitals are one of the primary end users of the cardiac AI monitoring and diagnostics market. By leveraging AI technology, these devices can assist healthcare professionals in detecting abnormalities, predicting cardiac events, and aiding in the diagnosis of various cardiac conditions The hospitals segment held a share of 58.22% in 2022 and is expected to grow at a CAGR of 26.06% during the forecast period 2023-2032.

Segmentation 5: by Region
•   North America - U.S., Canada
•   Europe - Germany, U.K., France, Spain, Italy, and Rest-of-Europe
•   Asia-Pacific - China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific
•   Latin America - Brazil, Mexico, and Rest-of-Latin America
•   Middle East and Africa - Israel, U.A.E., South Africa, and Rest-of-Middle East and Africa

The North America region holds the largest share in the global cardiac AI monitoring and diagnostics market owing to factors such as a pre-established and pre-existing technologically advanced healthcare system and greater digital adoption. Furthermore, Asia-Pacific is anticipated to register significant growth during the forecast period 2023-2032 owing to factors such as the shortage of healthcare workforce leading to increased demand for automation by AI and the increasing prevalence of cardiovascular diseases leading to increased demand for advanced technologies.

Recent Developments in the Cardiac AI Monitoring and Diagnostics Market

•   In May 2023, Volta AF-Xplorer, an AI-enabled software solution for atrial fibrillation provided by Volta Medical, received FDA clearance. The software is used to simplify complex atrial fibrillation procedures.
•   In May 2023, Koninklijke Philips N.V. acquired Philips DiA Imaging Analysis, an AI intelligence firm. This acquisition would enhance the position of the company in the cardiac AI monitoring and diagnostics market.
•   In April 2023, HeartFlow, Inc. announced the launch of its RoadMap analysis software solution in the U.S. The solution provides assistance in recognizing coronary artery narrowings in CT images.
•   In March 2023, Aidoc. launched its cardiovascular AI solutions package. Aidoc's cardiovascular solutions mechanically combine data and utilize AI algorithms to produce clinical insights for more efficient cardiac diagnosis.
•   In March 2023, Peerbridge Health, Inc. raised funding of $10 million. The funding round was led by Mendota Venture Capital and HealthX Ventures.
•   In February 2023, GE Healthcare announced that it would acquire Caption Health. Through this acquisition, the company would expand its ultrasound capability with AI-powered image guidance.
•   In February 2023, LVivo IQS, an AI-enabled software solution for cardiac ultrasound provided by DiA Imaging Analysis, received FDA clearance.
•   In January 2023, Volta Medical raised a funding of $40.4 million (€36 million) as a part of its series B funding round. The funding was raised to support the increased adoption of the company’s AI software solution for cardiac ablation.
•   In January 2023, Medicalgorithmics S.A. partnered with Express Diagnostics Limited for the distribution of its AI-integrated pocket ECG, the DeepRhythm AI, and analytics technologies in the U.K.
•   In January 2023, UltraSight and EchoNous, Inc. partnered to improve accessibility to cardiac ultrasound by integrating UltraSight's real-time AI guidance software with EchoNous, Inc.’s Kosmos handheld ultrasound device.
•   In November 2022, Siemens Healthineers AG and Vista.ai partnered to form a commercial agreement to introduce AI-driven image acquisition to MRI scanners in hospitals.

Demand – Drivers and Limitations

Market Demand Drivers:

High Burden of Cardiovascular Diseases Worldwide: The escalating burden of cardiovascular diseases (CVDs) worldwide has prompted a growing demand for innovative solutions to tackle this global health challenge, and one of the areas that has gained significant attention is the use of artificial intelligence (AI) diagnostics in cardiology. Therefore, the increasing burden of cardiovascular disease worldwide is driving the growth of the cardiac AI monitoring and diagnostics market.

Increasing Government Initiatives for AI Adoption: Governments around the world have recognized the potential of artificial intelligence (AI) in advancing cardiac diagnostics and have taken substantial initiatives to support research and development in this field. These initiatives aim to foster innovation, enhance healthcare outcomes, and address the burden of cardiovascular diseases.

Growing Research in the Field of AI for Cardiology: Artificial intelligence (AI) has the potential to revolutionize the field of cardiology by improving diagnostic accuracy, enhancing patient outcomes, and optimizing treatment strategies, and there has been a constant increase in research being conducted on the utilization of AL/ML algorithms for cardiac diagnostics, which is expected to propel the growth of the market.

Increasing Regulatory Approvals of Cardiac Diagnostics AI Medical Devices: There has been an increase in regulatory approvals for cardiac AI diagnostics devices over the past few years. Post-2020, the regulatory approvals for AI-based cardiac diagnostics solutions have been on a constant rise, which is leading to increased launch and adoption of new products in the cardiac AI monitoring and diagnostics market, thereby propelling the market growth.

Technological Advancements in the Field of Cardiac AI Diagnostics: Technological advancements in cardiac AI diagnostics have revolutionized the field of cardiovascular medicine, providing new tools and capabilities for more accurate and efficient diagnosis and treatment. There have been several notable advancements in the field which has propelled the adoption of these solutions.

Market Restraints:

Hesitation in Adoption and Acceptance of AI-Enabled Solutions for Cardiac Diagnosis: The adoption and acceptance of AI-enabled solutions for cardiac diagnosis by healthcare facilities can be low due to ethical and legal implications associated with their use.

Market Opportunities:

Increasing Opportunities for AI-Enabled Cardiac Diagnosis Solutions in Emerging Economies: Emerging economies such as India, China, and Brazil present an increasing opportunity for AI-enabled cardiac diagnosis solutions owing to several factors, such as the rising burden of cardiovascular diseases, lack of specialized healthcare professionals, and increasing research and development collaborations.

Partnerships and Alliances amongst Market Players Creating an Opportunity for Growth: Partnerships and collaborations among market players can create a significant opportunity for growth. They can facilitate the growth of a market player by leveraging shared expertise, increased customer base, enhanced product offering, access to new markets, access to new technologies, shared costs, increased credibility, and joint innovation.

Analyst’s Thoughts

According to Swati Sood, Principal Analyst – BIS Research, “Artificial Intelligence (AI) has shown great promise in the field of healthcare, and it can play a significant role in monitoring and diagnosing cardiovascular diseases. AI can enable precise forecasting of cardiovascular outcomes, non-invasive identification of coronary artery disease, recognition of malignant arrhythmia, and the monitoring, diagnosis, treatment, and prognostication of heart failure patients.”

Cardiac AI Monitoring and Diagnostics Market - A Global and Regional Analysis

Focus on Product, Type, Application, End User, and Country Analysis - Analysis and Forecast, 2023-2032

Get Free Sample

Schedule a Call

Some Faq's

Frequently Asked Questions

According to BIS Research, cardiac AI monitoring and diagnostics refers to the application of artificial intelligence (AI) technologies in the field of cardiology to monitor, analyze, and diagnose various cardiac conditions. AI algorithms are trained on large datasets of cardiac images, patient data, and clinical outcomes to develop models that can assist healthcare professionals in interpreting cardiac diagnostic tests and making treatment decisions. This emerging area of medical technology aims to improve the accuracy, efficiency, and accessibility of cardiac care.

The global cardiac AI monitoring and diagnostics market has seen major development by key players operating in the market, such as business expansions, partnerships, collaborations, regulatory and legal activities, funding activities, product launches, and acquisitions and mergers. According to BIS Research analysis, most of the companies preferred regulatory and legal activities and partnerships, alliances, and business expansions as a strategy to further increase their growth in the global cardiac AI monitoring and diagnostics market.

The following are the USPs of this report:

•   Key trends and opportunity assessment of the market
•   Regulatory framework
•   Ongoing clinical trials
•   Funding scenario
•   Entry barriers for new entrants
•   End user perception
•   Patent analysis
•   Case studies
•   Business models
•   Digital adoption at a regional level
•   Impact of COVID-19 on the market
•   Market dynamics, including drivers, restraints, and opportunities
•   Region and country-level analysis, including market dynamics, market size, and forecast
•   Cross-segmentation at the region level

The companies developing AI-enabled solutions for the diagnosis and monitoring of cardiac disease or the companies looking to leverage such technology in the field of cardiology should buy this report.

Artificial Intelligence/Machine Learning Medical Device Market - A Global and Regional Analysis: Foc

The global artificial intelligence/machine learning medical device market was valued at...

View Report

Published Year: 2021

Global AI in Healthcare Market: Analysis and Forecast, 2021-2030

The global AI in healthcare market is anticipated to reach $35,892.2 million by 2030,...

View Report

A quick peek into the report

Table of Contents

Market Report Coverage

How Can This Report Add Value to an Organization?

Industry and Technology Overview

$5500

Cardiac AI Monitoring and Diagnostics Market - A Global and Regional Analysis

Frequently Asked Questions

You may also like

Artificial Intelligence/Machine Learning Medical Device Market - A Global and Regional Analysis: Foc

Global AI in Healthcare Market: Analysis and Forecast, 2021-2030

Cardiac AI Monitoring and Diagnostics Market - A Global and Regional Analysis

A quick peek into the report

Table of Contents

1 Market

2 Industry Outlook

3 Impact of COVID-19

4 Business Dynamics

5 Global Cardiac AI Monitoring and Diagnostics Market (By Product)

6 Global Cardiac AI Monitoring and Diagnostics Market (By Application)

7 Global Cardiac AI Monitoring and Diagnostics Market (By Type)

8 Cardiac AI Monitoring and Diagnostics Market (By End User)

9 Regions

10 Markets - Competitive Benchmarking & Company Profiles

List of Tables

List of Figures

Market Report Coverage

How Can This Report Add Value to an Organization?

Industry and Technology Overview

$5500

Cardiac AI Monitoring and Diagnostics Market - A Global and Regional Analysis

Frequently Asked Questions

Q: What is cardiac AI monitoring and diagnostics?

Q: What kinds of new strategies are being adopted by the existing market players to strengthen their market position in the industry?

Q: What is the USP of this report?

Q: Who should buy this report?

You may also like

Artificial Intelligence/Machine Learning Medical Device Market - A Global and Regional Analysis: Foc

Global AI in Healthcare Market: Analysis and Forecast, 2021-2030